107 related articles for article (PubMed ID: 8886934)
21. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Wettstein JG; Grouhel A
Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
[TBL] [Abstract][Full Text] [Related]
22. Majonoside-R2 reverses social isolation stress-induced decrease in pentobarbital sleep in mice: possible involvement of neuroactive steroids.
Nguyen TT; Matsumoto K; Yamasaki K; Watanabe H
Life Sci; 1997; 61(4):395-402. PubMed ID: 9244365
[TBL] [Abstract][Full Text] [Related]
23. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of the antinociceptive action of the selective kappa-opioid receptor agonist, U-50,488H by ICS-205-930.
Ho BY; Takemori AE
Eur J Pharmacol; 1990 Mar; 178(3):371-3. PubMed ID: 2160372
[TBL] [Abstract][Full Text] [Related]
25. The possible modulation of morphine analgesia by the supramolecular GABA receptor complex.
Palaoglu O; Ayhan IH
Psychopharmacology (Berl); 1986; 90(2):244-6. PubMed ID: 3024198
[TBL] [Abstract][Full Text] [Related]
26. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice.
Suh HW; Song DK; Kim YH; Yoo JS; Tseng LF
Eur J Pharmacol; 1994 Sep; 263(1-2):217-21. PubMed ID: 7821357
[TBL] [Abstract][Full Text] [Related]
27. Socio-psychological stress-induced antinociception in diabetic mice.
Kamei J; Ohsawa M
Psychopharmacology (Berl); 2000 May; 149(4):397-400. PubMed ID: 10867967
[TBL] [Abstract][Full Text] [Related]
28. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
29. The differential effects of histamine receptor antagonists on morphine- and U-50,488H-induced antinociception in the mouse.
Suzuki T; Takamori K; Takahashi Y; Narita M; Misawa M; Onodera K
Life Sci; 1994; 54(3):203-11. PubMed ID: 7904710
[TBL] [Abstract][Full Text] [Related]
30. Pentobarbital, diazepam, and ethanol abolish the interphase diminution of pain in the formalin test: evidence for pain modulation by GABAA receptors.
Franklin KB; Abbott FV
Pharmacol Biochem Behav; 1993 Nov; 46(3):661-6. PubMed ID: 8278443
[TBL] [Abstract][Full Text] [Related]
31. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Lutfy K; Doan P; Nguyen M; Weber E
Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
[TBL] [Abstract][Full Text] [Related]
32. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
33. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
34. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
[TBL] [Abstract][Full Text] [Related]
35. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
36. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
Lutfy K; Doan P; Nugyen M; Weber E
Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
[TBL] [Abstract][Full Text] [Related]
37. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
[TBL] [Abstract][Full Text] [Related]
38. Stimulatory effect of diazepam on gastric acid secretion in the continuously perfused stomach in rats under urethane anesthesia.
Lin WC
Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):157-68. PubMed ID: 9090752
[TBL] [Abstract][Full Text] [Related]
39. Reversal of the effect of centrally-administered diazepam on morphine antinociception by specific (Ro 15-1788 and Ro 15-3505) and non-specific (bicuculline and caffeine) benzodiazepine antagonists.
Zambotti F; Zonta N; Tammiso R; Ferrario P; Hafner B; Mantegazza P
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):43-6. PubMed ID: 3090455
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1021-7. PubMed ID: 7680715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]